Venus Remedies Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the EQ series, hit its maximum allowed daily loss of 5.0%, consistent with its 5% price band. The closing price of Rs 949.60 marked a decline of Rs 49.95 from the previous close, with the intraday low matching the circuit floor. This price band restriction effectively froze trading at the floor price, as sellers overwhelmed demand to the point where the exchange's circuit breaker intervened. The total traded volume was 74,685 shares, with a turnover of approximately Rs 7.11 crore. Despite this turnover, the presence of unfilled supply is evident as the price could not move lower due to the circuit limit. How sustainable is this selling pressure and what does it imply for the stock’s immediate liquidity?

Delivery and Volume Analysis

Delivery volumes on 23 Apr 2026 surged to 55,700 shares, an increase of 82.94% compared to the 5-day average delivery volume. On a lower circuit day, rising delivery volumes are a critical indicator — they reflect genuine liquidation by holders rather than speculative short-selling. This suggests that the selling pressure is not merely intraday trading but actual dumping of holdings, signalling capitulation or forced exits. The weighted average price also leaned towards the lower end of the day’s range, reinforcing the dominance of sellers. The total traded volume, while mechanically constrained by the circuit lock, was lower than typical sessions, which is common in such scenarios but does not indicate easing selling pressure.

Intraday Price Action

The stock opened at Rs 984.75, already down 3.26% from the previous close, and steadily declined throughout the session to close at the circuit low of Rs 949.60. This intraday range of Rs 35.15 represents a 3.57% swing within the day, culminating in the maximum permitted loss. The weighted average price being closer to the low indicates that most trading activity clustered near the circuit floor, with sellers unable to find buyers at higher levels. This steady downward arc highlights persistent selling pressure rather than a sudden flash crash, emphasising the difficulty holders faced in exiting positions during the session.

Moving Averages and Trend Context

Technically, Venus Remedies Ltd remains below its 5-day moving average, confirming short-term weakness. However, it is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating that the longer-term trend has not yet fully broken down. This mixed technical picture suggests that while the immediate momentum is negative, the stock has not yet entered a sustained downtrend. Does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk for a Micro-Cap

With a market capitalisation of Rs 1,335 crore, Venus Remedies Ltd is classified as a micro-cap stock. Its liquidity profile is moderate, with a trade size of Rs 0.12 crore based on 2% of the 5-day average traded value. While this suggests some capacity for trading, the lower circuit lock creates a significant exit risk for holders. Sellers who wish to exit positions face a bottleneck as the circuit prevents the price from falling further, and buyers remain absent at these levels. This can lead to multi-day circuit locks, compounding the challenge of liquidating holdings in a timely manner. With unfilled sell orders at Rs 949.60 and near-zero liquidity, how deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space often characterised by volatility linked to regulatory developments and product pipelines. While the company’s micro-cap status means it is more susceptible to liquidity shocks, its sector positioning provides some fundamental support. However, the current price action reflects a market environment where selling pressure has overwhelmed demand, irrespective of sector trends.

Conclusion: Severity Assessment and Liquidity Caveats

The 5.0% single-day loss culminating in a lower circuit lock for Venus Remedies Ltd is a clear indication of persistent selling pressure and genuine liquidation by holders, as evidenced by the surge in delivery volumes. The intraday price trajectory and technical positioning below the 5-day moving average confirm short-term weakness, while the micro-cap liquidity profile raises concerns about the ability of sellers to exit without further price concessions. The circuit breaker has effectively frozen the price, but not the supply, creating a scenario where sellers remain trapped with limited exit options. After a 5.0% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today